Publicacións en colaboración con investigadores/as de University of California, San Diego (2)

2022

  1. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

    The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 2, pp. 128-140

2016

  1. Ustekinumab as induction and maintenance therapy for Crohn's disease

    New England Journal of Medicine, Vol. 375, Núm. 20, pp. 1946-1960